SM
IRD

Sabby Management’s Opus Genetics IRD Stock Holding History

Sabby Management’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-3,540
Closed -$411K – 189
2017
Q3 		$411K Sell
3,540
-1,605
-31% -$173K 0.03% 108
2017
Q2 		$706K Buy
+5,145
New +$1M 0.05% 119
2017
Q1 		– Sell
-15,264
Closed -$1.04M – 325
2016
Q4 		$1.04M Sell
15,264
-4,454
-23% -$362K 0.06% 140
2016
Q3 		$1.99M Buy
19,718
+820
+4% +$99.1K 0.07% 132
2016
Q2 		$2.28M Sell
18,898
-8,628
-31% -$1.21M 0.12% 101
2016
Q1 		$4.36M Buy
+27,526
New +$4.58M 0.22% 49
2013
Q4 		– Sell
-4,689
Closed -$1.01M – 250
2013
Q3 		$1.01M Buy
+4,689
New +$1.09M 0.07% 123

Other funds holding IRD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Zurich Cantonal Bank
Zurich Cantonal Bank Zurich, Switzerland $46B AUM 27.59% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HVIA
Hudson Valley Investment Advisors Goshen, New York $823M AUM 31.4% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sabby Management's IRD Position: Q4 2017 in Review

Sabby Management sold out of Opus Genetics (IRD) in Q4 2017, closing a stake of 3,540 shares — an estimated $411K sold.

Sabby Management first reported a position in IRD in Q3 2013 and held it in 7 quarters. The position peaked at $4.36M in Q1 2016. 28 funds tracked by Wall St. Rank hold IRD as of Q4 2017.

  • Sabby Management reported no remaining Opus Genetics position as of Q4 2017 after selling out during the quarter.
  • Sabby Management sold 3,540 Opus Genetics shares in Q4 2017, an estimated $411K.
  • Sabby Management first reported a position in Opus Genetics in Q3 2013 and held it in 7 quarters.
  • Sabby Management's Opus Genetics position peaked at $4.36M in Q1 2016.
  • 28 funds tracked by Wall St. Rank held Opus Genetics as of Q4 2017.

Based on Sabby Management's 13F filing for Q4 2017, filed 14 Feb 2018.